# Three Decades of Use of the Minimum Basic Data Set in Infectious Disease Research in Spain: A Scoping Review with an Evidence-Mapping Approach

**Authors:** Beatriz Rodríguez-Alonso, Hugo Almeida, Montserrat Alonso-Sardón, Inmaculada Izquierdo, Ángela Romero-Alegría, Amparo López-Bernús, Virginia Velasco-Tirado, Josué Pendones Ulerio, Javier Pardo Lledías, Moncef Belhassen-García

PMC · DOI: 10.3390/tropicalmed11020061 · Tropical Medicine and Infectious Disease · 2026-02-20

## TL;DR

This paper reviews 30 years of infectious disease research in Spain using hospital discharge data, highlighting its impact and limitations.

## Contribution

The study provides the first comprehensive evidence map of CMBD-based infectious disease research in Spain.

## Key findings

- 359 studies using CMBD data were identified, focusing mainly on respiratory and vaccine-preventable infections.
- Most research was retrospective observational, with limited regional representation and data limitations.
- CMBD's lack of clinical detail and coding consistency hinders causal inference.

## Abstract

Nationwide hospital discharge databases are increasingly used in infectious disease research, yet their methodological strengths and limitations are rarely synthesised. In Spain, the Minimum Basic Data Set (Conjunto Mínimo Básico de Datos, CMBD) was implemented in 1987 and provides near-universal coverage of acute-care hospitalisations and has been widely applied in infectious disease epidemiology. However, its overall contribution and intrinsic constraints have not been comprehensively mapped. Given the breadth of infections, study designs, populations and outcome definitions in CMBD-based research, effect-size synthesis was not feasible; therefore, we conducted a scoping review with an evidence-mapping approach. We aimed to synthesise the scope, applications and methodological limitations of CMBD-based infectious disease research since its implementation. We conducted a scoping review following JBI guidance and reported according to PRISMA-ScR. PubMed, Embase, Web of Science and Scopus were searched from inception to 25 November 2024 for peer-reviewed journal articles in English or Spanish using CMBD data to investigate infectious diseases in Spain (no restrictions were applied by study design; grey literature was excluded). Screening, data charting and synthesis were completed during 2025. Four reviewers independently screened records and charted data. Studies were classified by infectious disease focus, syndromic category, study design and geographical scope. A total of 359 studies published between 1996 and 2024 were included, mostly retrospective observational analyses. Infectious diseases were the primary focus in 225 studies (62.7%), most commonly respiratory, gastrointestinal/liver and vaccine-preventable infections. Subnational analyses were concentrated in a limited number of regions. Over 80% of reported limitations reflected intrinsic CMBD features. Over three decades, the CMBD has become a cornerstone of hospital-based infectious disease research in Spain, enabling robust national analyses. However, limitations in clinical detail, microbiological confirmation and coding consistency constrain aetiological specificity and causal inference, highlighting the need for data validation and linkage with complementary sources.

## Linked entities

- **Diseases:** respiratory infections (MONDO:0024355)

## Full-text entities

- **Diseases:** Infectious Disease (MESH:D003141), sepsis (MESH:D018805), chronic diseases (MESH:D002908), fungal (MESH:D009181), bacterial and CNS infections (MESH:D002494), rotavirus gastroenteritis (MESH:D012400), herpes zoster (MESH:D006562), chronic obstructive pulmonary disease (MESH:D029424), gastrointestinal and liver infections (MESH:D017093), pneumococcal pneumonia (MESH:D011018), tropical and parasitic infections (MESH:D010272), pneumonia (MESH:D011014), Postherpetic neuralgia (MESH:D051474), Tuberculosis (MESH:D014376), CMBD (MESH:D005862), bacterial (MESH:D001424), Chickenpox (MESH:D002644), urinary tract infections (MESH:D014552), Infection (MESH:D007239), cardiovascular disease (MESH:D002318), HIV and sexually transmitted infections (MESH:D012749), postoperative complications (MESH:D011183), postsurgical (MESH:D010149), cancer (MESH:D009369), COVID-19 (MESH:D000086382), respiratory diseases (MESH:D012140), influenza (MESH:D007251), pneumococcal disease (MESH:D011008), hip fracture (MESH:D006620), viral hepatitis (MESH:D014777), respiratory infections (MESH:D012141), imported/ (MESH:D000076263), injury to (MESH:D014947), healthcare-associated infections (MESH:D003428)
- **Chemicals:** CMBD (-)
- **Species:** Bordetella pertussis (species) [taxon 520], Homo sapiens (human, species) [taxon 9606], Respiratory syncytial virus (no rank) [taxon 12814]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12945255/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12945255/full.md

## References

383 references — full list in the complete paper: https://tomesphere.com/paper/PMC12945255/full.md

---
Source: https://tomesphere.com/paper/PMC12945255